英科医疗: 董事会专门委员会工作制度

Core Points - The company establishes specialized committees to enhance governance and strategic development, including the Strategic and ESG Committee, Nomination Committee, Audit Committee, and Compensation and Assessment Committee [1][2][3] Strategic and ESG Committee - The Strategic and ESG Committee is responsible for analyzing global economic and industry trends, researching the company's development strategy, and providing recommendations on public policies and sustainable development [2][3] - The committee consists of three directors, including one independent director, and is chaired by the chairman of the board [2][3] - The committee's responsibilities include evaluating long-term development strategies, major investment decisions, and assessing ESG-related risks and opportunities [3][4] Nomination Committee - The Nomination Committee is tasked with selecting candidates for the board of directors and senior management, ensuring compliance with relevant laws and company regulations [6][7] - It comprises three directors, with at least two being independent directors, and is chaired by an independent director [6][7] - The committee's recommendations must be documented and disclosed if not fully adopted by the board [7][8] Audit Committee - The Audit Committee oversees the company's financial reporting, internal controls, and external audit processes [10][11] - It consists of three members, all of whom must be non-executive directors, with a majority being independent directors [10][11] - The committee is responsible for reviewing financial reports and ensuring compliance with legal and regulatory requirements [11][12] Compensation and Assessment Committee - The Compensation and Assessment Committee develops performance evaluation standards and compensation policies for directors and senior management [11][13] - It is composed of three directors, with a majority being independent directors, and is chaired by an independent director [11][13] - The committee's recommendations regarding compensation must be approved by the board and disclosed to shareholders [13][14]